PositiveID (PSID) Pops on Strategic Relationship with Raytheon Microelectronics Espana
PositiveID Corporation (Nasdaq: PSID) shares are rocking today following a disclosure with the U.S. Securities and Exchange Commission confirming a strategic relationship with Raytheon Microelectronics Espana S.A.. The stock is up over 8% early today.
According to the filing: "Raytheon's unit will use the PositiveID’s intellectual property to develop and manufacture the Company’s 8-millimeter microchip.
Per the letter agreement, Raytheon has agreed to provide technical, developmental and production support for the Company’s 8-millimeter microchip to be used for the Company’s medical device customers, including Medical Components, Inc.
PositiveID has agreed to sell its 8-millimeter microchip to Medcomp for implantation into Medcomp’s vascular ports. This strategic relationship with Raytheon is expected to support those sales."
According to the filing: "Raytheon's unit will use the PositiveID’s intellectual property to develop and manufacture the Company’s 8-millimeter microchip.
Per the letter agreement, Raytheon has agreed to provide technical, developmental and production support for the Company’s 8-millimeter microchip to be used for the Company’s medical device customers, including Medical Components, Inc.
PositiveID has agreed to sell its 8-millimeter microchip to Medcomp for implantation into Medcomp’s vascular ports. This strategic relationship with Raytheon is expected to support those sales."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Battalion Oil takes equity stake in AI software firm Collide
- CBRE Global Real Estate Income Fund adjusts September distribution after split
- GrabAGun names John Swanagon as chief technology officer
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share